551.85
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ISRG Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$553.29
Aprire:
$550.68
Volume 24 ore:
1.71M
Relative Volume:
0.80
Capitalizzazione di mercato:
$197.79B
Reddito:
$8.71B
Utile/perdita netta:
$2.48B
Rapporto P/E:
80.92
EPS:
6.82
Flusso di cassa netto:
$1.75B
1 W Prestazione:
+0.30%
1M Prestazione:
+4.24%
6M Prestazione:
+1.87%
1 anno Prestazione:
+36.64%
Intuitive Surgical Inc Stock (ISRG) Company Profile
Nome
Intuitive Surgical Inc
Settore
Industria
Telefono
(408) 523-2100
Indirizzo
1020 KIFER ROAD, SUNNYVALE
Confronta ISRG con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ISRG
Intuitive Surgical Inc
|
551.85 | 197.20B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
170.66 | 50.02B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
85.43 | 42.88B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
247.05 | 36.10B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
BAX
Baxter International Inc
|
30.09 | 15.84B | 11.89B | -560.00M | 191.00M | -1.10 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2024-08-02 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
2024-07-10 | Reiterato | Citigroup | Buy |
2024-05-30 | Iniziato | Goldman | Buy |
2023-11-17 | Iniziato | HSBC Securities | Buy |
2023-07-19 | Iniziato | Robert W. Baird | Outperform |
2023-04-19 | Reiterato | BTIG Research | Buy |
2023-04-19 | Reiterato | BofA Securities | Buy |
2023-04-19 | Reiterato | Citigroup | Buy |
2023-04-19 | Reiterato | Evercore ISI | In-line |
2023-04-19 | Reiterato | JP Morgan | Overweight |
2023-04-19 | Reiterato | Morgan Stanley | Equal-Weight |
2023-04-19 | Reiterato | RBC Capital Mkts | Outperform |
2023-04-19 | Reiterato | Raymond James | Outperform |
2023-04-19 | Reiterato | Stifel | Buy |
2023-04-19 | Reiterato | Truist | Buy |
2023-04-19 | Reiterato | Wells Fargo | Overweight |
2023-03-29 | Iniziato | UBS | Neutral |
2023-03-23 | Iniziato | William Blair | Outperform |
2022-10-18 | Iniziato | Barclays | Overweight |
2022-10-13 | Iniziato | Mizuho | Neutral |
2022-10-12 | Iniziato | Jefferies | Hold |
2022-04-13 | Iniziato | Truist | Buy |
2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
2022-03-25 | Iniziato | RBC Capital Mkts | Outperform |
2022-03-02 | Ripresa | BofA Securities | Buy |
2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
2022-01-31 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2022-01-25 | Downgrade | Redburn | Buy → Neutral |
2022-01-21 | Reiterato | BTIG Research | Buy |
2022-01-21 | Aggiornamento | Citigroup | Neutral → Buy |
2022-01-21 | Reiterato | Deutsche Bank | Hold |
2022-01-21 | Reiterato | Evercore ISI | In-line |
2022-01-21 | Reiterato | Morgan Stanley | Equal-Weight |
2022-01-21 | Reiterato | Piper Sandler | Neutral |
2022-01-21 | Reiterato | Raymond James | Outperform |
2022-01-21 | Reiterato | Robert W. Baird | Outperform |
2022-01-21 | Reiterato | Stifel | Buy |
2022-01-21 | Reiterato | UBS | Neutral |
2022-01-21 | Reiterato | Wells Fargo | Overweight |
2022-01-10 | Aggiornamento | BTIG Research | Neutral → Buy |
2021-10-01 | Downgrade | Citigroup | Buy → Neutral |
2021-07-21 | Reiterato | BofA Securities | Neutral |
2021-07-21 | Reiterato | Citigroup | Buy |
2021-07-21 | Reiterato | JP Morgan | Overweight |
2021-07-21 | Reiterato | Morgan Stanley | Equal-Weight |
2021-07-21 | Reiterato | Piper Sandler | Neutral |
2021-07-21 | Reiterato | SVB Leerink | Mkt Perform |
2021-07-21 | Reiterato | Stifel | Buy |
2021-07-21 | Reiterato | UBS | Neutral |
2021-07-21 | Reiterato | Wells Fargo | Overweight |
2021-07-14 | Reiterato | Goldman | Buy |
2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
2021-04-21 | Aggiornamento | Oppenheimer | Underperform → Perform |
2021-04-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2021-04-01 | Iniziato | Citigroup | Buy |
2020-12-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-09-28 | Iniziato | Argus | Buy |
2020-09-11 | Iniziato | Wolfe Research | Outperform |
2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
2020-09-02 | Iniziato | Robert W. Baird | Neutral |
2020-07-20 | Reiterato | Bernstein | Outperform |
2020-04-28 | Downgrade | Piper Sandler | Overweight → Neutral |
2020-04-17 | Downgrade | CFRA | Hold → Sell |
2020-04-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2020-04-09 | Downgrade | Evercore ISI | In-line → Underperform |
2020-04-01 | Downgrade | Oppenheimer | Perform → Underperform |
2020-01-27 | Downgrade | Deutsche Bank | Buy → Hold |
2019-12-12 | Reiterato | Wells Fargo | Outperform |
2019-11-21 | Iniziato | Oppenheimer | Perform |
2019-07-19 | Reiterato | Canaccord Genuity | Buy |
2019-04-22 | Reiterato | Canaccord Genuity | Buy |
2019-04-02 | Iniziato | Deutsche Bank | Buy |
2018-10-31 | Reiterato | Piper Jaffray | Overweight |
2018-10-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
Mostra tutto
Intuitive Surgical Inc Borsa (ISRG) Ultime notizie
How Is Intuitive Surgical's Stock Performance Compared to Other Healthcare Stocks? - MSN
Tariff-driven uncertainty rattles medtech industry - Fierce Biotech
Goldman Sachs Sticks to Their Buy Rating for Intuitive Surgical (ISRG) - The Globe and Mail
Radiology Oncology Surgical Robot Market Deep Research Report - openPR.com
Robotics Surgical Simulation Systems Market Deep Research - openPR.com
Intuitive Surgical: More Than Robots – Why Its AI-Powered Platform Deserves A Premium - Seeking Alpha
How Is Intuitive Surgical's Stock Performance Compared To Other Healthcare Stocks? - Barchart.com
Goldman Sachs Adjusts Price Target on Intuitive Surgical to $636 From $569, Maintains Buy Rating - marketscreener.com
Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Stock Has Fared Decently: Is the Market Following Strong Financials? - simplywall.st
$100 Invested In Intuitive Surgical 5 Years Ago Would Be Worth This Much Today - Benzinga
(ISRG) Technical Data - news.stocktradersdaily.com
Intuitive Surgical (ISRG) Stock Sees Minor Dip: Key Price Levels and Growth Prospects - Daily Chhattisgarh News
The Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, Intuitive Surgical, Hamilton Beach Brands and AXIL Brands - Nasdaq
Intuitive Surgical, Inc. (ISRG) Laps the Stock Market: Here's Why - Yahoo Finance
Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical - MSN
ISRG vs. MDT: Which Robotic Surgery Stock Is a Smarter Buy Now? - Yahoo Finance
Opportunities for the Global Medical Service Robotics Market - openPR.com
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Intuitive Surgical Stock: Moat, Resilience But High Market Expectations (NASDAQ:ISRG) - Seeking Alpha
Intuitive Surgical (NASDAQ:ISRG): Strongest Q1 Results from the Surgical Equipment & ConsumablesSpecialty Group - Yahoo Finance
Prostate Biopsies Device Market May See a Big Move | Major Giants- Medtronic, Intuitive Surgical, Hologic - openPR.com
30 years of Innovation and Impact: Dan Larson's Inspiring Story - GlobeNewswire
Intuitive Celebrates 30 Years of Innovation in Robotic-Assisted Surgery with Patient Success Story from Lung Cancer Survivor Dan Larson - Nasdaq
From Boeing Engineer to Cancer Survivor: How Intuitive's Robotic Surgery Changed One Man's Life - Stock Titan
Intuitive Surgical: The Business Model Of Robotic Surgery Supports A Bullish Outlook - Seeking Alpha
Navigated Surgical Robot Market Outlook and Future Projections for 2030 - openPR.com
Minimally Invasive Surgical Robot System Market Outlook and Future Projections for 2030 - openPR.com
Hong Kong surgical robot start-up Cornerstone takes aim at da Vinci - South China Morning Post
Autonomous Surgical Robotics Market Outlook and Future Projections for 2030 - openPR.com
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.58%: What You Should Know - MSN
Insights into the Robotic Patient Care Solutions Market 2025: - openPR.com
Endoscopy Devices Global Market Overview 2021-2030 with Forecasts 2024-2030 - GlobeNewswire Inc.
Citigroup Raises Price Target on ISRG to $650, Maintains Buy Rat - GuruFocus
Citi Boosts Price Target for Intuitive Surgical (ISRG) to $650 | ISRG Stock News - GuruFocus
Citigroup Adjusts Price Target on Intuitive Surgical to $650 From $590, Maintains Buy Rating - marketscreener.com
2 Stocks That Turned $1,000 Into More Than $8,000 in 10 Years to Buy and Hold - The Motley Fool
Surgical Robot Maker to Become City’s Biggest Employer with $540M Campus Expansion - Peachtree Corners Magazine
$1000 Invested In Intuitive Surgical 20 Years Ago Would Be Worth This Much Today - Benzinga
Do Wall Street Analysts Like Intuitive Surgical Stock? - MSN
The End of an Era: Intuitive Surgical Names New CEO - Medical Device and Diagnostic industry
How to Take Advantage of moves in (ISRG) - news.stocktradersdaily.com
Spinal Surgical Robots Market Is Going to Boom | Major Giants Medtronic, Renishaw, Orthofix Medical - openPR.com
Medical Technology Company Intuitive Expanding in Peachtree Corners, Adding Approximately 1,200 New Jobs - Peachtree Corners Magazine
Olympus Hires Former Intuitive VP Slawek Kierner as Chief Digital Officer - Medical Product Outsourcing
Intuitive Surgical (ISRG) Sees Surge in Bullish Options Activity - GuruFocus
Robot-assisted Surgery Market Is Booming Worldwide 2025-2032 | - openPR.com
Olympus adds former Intuitive digital leader as chief digital officer - MassDevice
Medical Robots Market 2025-2032: Top Trends & Growth Drivers | - openPR.com
A human touch: WinnMed eyeing purchase of modern surgical robot - Decorah Leader
Intuitive Surgical Slips After CEO Gary Guthart Unexpectedly Steps Down - MSN
Intuitive Surgical (NasdaqGS:ISRG) Announces Leadership Transition With Dave Rosa as New CEO - simplywall.st
Intuitive Surgical Inc Azioni (ISRG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):